Sale!

Community Acquired Pneumonia: Controversies and Questions, an Issue of Infectious Disease Clinics, 1e (The Clinics: Internal Medicine)

Name: Community Acquired Pneumonia: Controversies and Questions, an Issue of Infectious Disease Clinics, 1e (The Clinics: Internal Medicine)
SKU: 2780
Availability: InStock

Original price was: $89.Current price is: $5.

PDF , File Size = 3.70 MB

Categories: An Issue of Series, Elsevier, Infectious Disease, Internal Medicine, Respiratory Medicine Tag: Community Acquired Pneumonia: Controversies and Questions an Issue of Infectious Disease Clinics 1e (The Clinics: Internal Medicine)

Description
Reviews (0)

Pneumonia is the leading cause of death due to infectious disease. This issue of Infectious Disease Clinics, guest edited by Tom File, focuses on the controversies and questions surrounding community-acquired pneumonia, including the potential benefits of identifying biomarkers for management of CAP (which could someday become a part of routine diagnostic testing for CAP), the best therapies for influenza/viral causes of pneumonia (the most common form of the disease in children), and clinical scoring tools to help predict long term outcomes. The issue also discusses how to approach MRSA as a cause of CAP and how to approach the non-responding patient.